We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
- Authors
Prabhu, Vimalanand S.; Cornely, Oliver A.; Golan, Yoav; Dubberke, Erik R.; Heimann, Sebastian M.; Hanson, Mary E.; Liao, Jane; Pedley, Alison; Dorr, Mary Beth; Marcella, Stephen
- Abstract
We estimated 30-day all-cause and Clostridium difficile infection (CDI)-associated hospital readmissions in participants at high risk of recurrent CDI enrolled in MODIFY I/II. Bezlotoxumabtreated inpatients experienced fewer CDI-associated readmissions compared with placebo-treated inpatients, notably in participants aged =65 years and with severe CDI.
- Subjects
THERAPEUTIC use of monoclonal antibodies; ANTIBIOTICS; CLOSTRIDIOIDES difficile; CLOSTRIDIUM diseases; CONFIDENCE intervals; RESEARCH funding; STATISTICS; DATA analysis; SECONDARY analysis; PATIENT readmissions; DESCRIPTIVE statistics; LEUKOCYTE count
- Publication
Clinical Infectious Diseases, 2017, Vol 65, Issue 7, p1218
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/cix523